Hydrogen sulfide attenuates cardiac hypertrophy and fibrosis induced by abdominal aortic coarctation in rats

Molecular Medicine Reports

Volumn 5, Issue 4, 2012, Pages 923-928

  Huang, Jinglong ^a   Wang, Dongming ^a   Zheng, Jinbin ^a   Huang, Xiansheng ^a   Jin, Hong ^a  

^a SHANTOU UNIVERSITY   (China)

Author keywords

Angiotensin II; Cardiac hypertrophy; Hydrogen sulfide

Indexed keywords

ANGIOTENSIN II; COLLAGEN; CONNEXIN 43; ENALAPRIL; HYDROGEN SULFIDE;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA COARCTATION; ARTICLE; CELL SIZE; CONTROLLED STUDY; HEART LEFT VENTRICLE MASS; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT;

ANGIOTENSIN II; ANIMALS; ANTIHYPERTENSIVE AGENTS; AORTIC COARCTATION; CARDIOMEGALY; CONNEXIN 43; ENALAPRIL; FIBROSIS; HYDROGEN SULFIDE; MALE; MYOCYTES, CARDIAC; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 84863291061     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.748     Document Type: Article

References (31)

1. Indolfi C, Di Lorenzo E, Perrino C, et al: Hydroxymethylglutaryl coenzyme A reductase inhibitor simvastatin prevents cardiac hypertrophy induced by pressure overload and inhibits p21ras activation. Circulation 106: 2118-2124, 2002. (Pubitemid 35192819)
2. Yasunari K, Maeda K, Nakamura M, et al: Left ventricular hypertrophy and angiotensin II receptor blocking agents. Curr Med Chem Cardiovasc Hematol Agents 3: 61-67, 2005. (Pubitemid 40057732)
3. Nishikimi T and Matsuoka H: Cardiac adrenomedullin: its role in cardiac hypertrophy and heart failure. Curr Med Chem Cardiovasc Hematol Agents 3: 231-242, 2005. (Pubitemid 40974783)
4. Manabe I, Shindo T, Nagai R, et al: Gene expression in fibroblasts and fibrosis: involvement in cardiac hypertrophy. Circ Res 91: 1103-1113, 2002. (Pubitemid 36076358)
5. Brilla CG, Funck RC, Rupp H, et al: Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease. Circulation 102: 1388-1393, 2000.
6. López B, Querejeta R, Varo N, et al: Usefulness of serum carboxy-terminal propeptide of procollagen type I in assessment of the cardioreparative ability of antihypertensive treatment in hypertensive patients. Circulation 104: 286-291, 2001. (Pubitemid 32666949)
7. Teunissen BE, Jongsma HJ and Bierhuizen MF: Regulation of myocardial connexins during hypertrophic remodeling. Eur Heart J 25: 1979-1989, 2004. (Pubitemid 39486016)
8. Kostin S, Dammer S, Hein S, et al: Connexin43 expression and distribution in compensated and decompensated cardiac hypertrophy in patients with aortic stenosis. Cardiovasc Res 62: 426-436, 2004. (Pubitemid 38496555)
9. Danik SB, Liu F and Zhang J: Modulation of cardiac gap junction expression and arrhythmic susceptibility. Circ Res 95: 1035-1041, 2004. (Pubitemid 39532334)
10. Moore PK, Bhatia M, Moochhala S, et al: Hydrogen sulfide: from the smell of the past to the mediator of the future? Trends Pharmacol Sci 24: 609-611, 2003. (Pubitemid 37494778)
11. Tang CS, Li XH, Du JB, et al: Hydrogen sulfide as a new endogenous gaseous transmitter in the cardiovascular system. Curr Vasc Pharmacol 4: 17-22, 2006.
12. Shibuya N, Tanaka M, Yoshida M, et al: 3-Mercaptopyruvate sulfurtransferase produces hydrogen sulfide and bound sulfane sulfur in the brain. Antioxid Redox Signal 11: 703-714, 2009.
13. Shibuya N, Mikami Y, Kimura Y, et al: Vascular endothelium expresses 3-mercaptopyruvate sulfurtransferase and produces hydrogen sulfide. J Biochem 146: 623-626, 2009.
14. Elrod JW, Calvert JW and Morrison J: Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. Proc Natl Acad Sci USA 104: 15560-15565, 2007. (Pubitemid 47502956)
15. 2S as a novel endogenous gaseous K (ATP) channel opener. EMBO J 20: 6008-6016, 2001.
16. Bian JS, Yong QC, Pan TT, et al: Role of hydrogen sulfifide in the cardioprotection caused by ischemic preconditioning in the rat heart and cardiac myocytes. J Pharmacol Exp Ther 316: 670-678, 2006.
17. Phrommintikul A, Tran L and Kompa A: Effects of a Rho kinase inhibitor on pressure overload induced cardiac hypertrophy and associated diastolic dysfunction. Am J Physiol Heart Circ Physiol 294: H1804-H1814, 2008. (Pubitemid 351490610)
18. Reddy K and Enwemeka CS: A simplified method for the analysis of hydroxyproline in biological tissues. Clin Biochem 29: 225-229, 1996.
19. Izumiya Y, Kim S, Izumi Y, et al: Apoptosis signal-regulating kinase 1 plays a pivotal role in angiotensin II-induced cardiac hypertrophy and remodeling. Circ Res 93: 874-883, 2003. (Pubitemid 37363062)
20. Dahlöf B: Left ventricular hypertrophy and angiotensin II antagonists. Am J Hypertens 14: 174-182, 2001.
21. González A, López B, Díez J, et al: Fibrosis in hypertensive heart disease: role of the renin-angiotensin-aldosterone system. Med Clin North Am 88: 83-97, 2004. (Pubitemid 38160942)
22. Park CM, Nagel RL, Blumberg WE, et al: Sulfhemoglobin. Properties of partially sulfurated tetramers. J Biol Chem 261: 8805-8810, 1986. (Pubitemid 17205079)
23. Laggner H, Hermann M, Esterbauer H, et al: The novel gaseous vasorelaxant hydrogen sulfide inhibits angiotensin-converting enzyme activity of endothelial cells. J. Hypertens 25: 2100-2104, 2007. (Pubitemid 47476307)
24. Kimura Y, Goto Y, Kimura H, et al: Hydrogen sulfide increases glutathione production and suppresses oxidative stress in mitochondria. Antioxid Redox Signal 12: 1-13, 2010.
25. Seddon M, Looi YH, Shah AM, et al: Oxidative stress and redox signalling in cardiac hypertrophy and heart failure. Heart 93: 903-907, 2007. (Pubitemid 47122034)
26. Pahor M, Bernabei R, Sgadari A, et al: Enalapril prevents cardiac fibrosis and arrhythmias in hypertensive rats. Hypertension 18: 148-157, 1991.
27. Li X, Jin H, Bin G, et al: Endogenous hydrogen sulfide regulates pulmonary artery collagen remodeling in rats with high pulmonary blood flow. Exp Biol Med (Maywood) 234: 504-512, 2009.
28. Roell W, Lewalter T, Sasse P, et al: Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia. Nature 450: 819-824, 2007. (Pubitemid 350237591)
29. Bacharova L, Plandorova J, Klimas J, et al: Discrepancy between increased left ventricular mass and 'normal' QRS voltage is associated with decreased connexin 43 expression in early stage of left ventricular hypertrophy in spontaneously hypertensive rats. J Electrocardiol 41: 730-734, 2008.
30. Severs NJ: Gap junction-mediated intercellular signaling in health and disease. Novartis Foundation Symposium 219: 188-211, 1999.
31. van Wamel AJ, Ruwhof C, van der Valk-Kokshoom LE, et al: The role of angiotensin II, endothelin-I and transforming growth factor-beta as autocrine/paracrine mediators of stretch-induced cardiomyocyte hypertrophy. Mol Cell Biochem 218: 113-124, 2001. (Pubitemid 32297584)